V005-9981 Screening compound: 2-({4-[2-hydroxy-3-(piperidin-1-yl)propyl]piperazin-1-yl}methyl)-N-{[3-(trifluoromethyl)phenyl]methyl}-1,3-oxazole-4-carboxamide

V005-9981 Screening compound: 2-({4-[2-hydroxy-3-(piperidin-1-yl)propyl]piperazin-1-yl}methyl)-N-{[3-(trifluoromethyl)phenyl]methyl}-1,3-oxazole-4-carboxamide
V005-9981 Screening compound: 2-({4-[2-hydroxy-3-(piperidin-1-yl)propyl]piperazin-1-yl}methyl)-N-{[3-(trifluoromethyl)phenyl]methyl}-1,3-oxazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V005-9981
2-({4-[2-hydroxy-3-(piperidin-1-yl)propyl]piperazin-1-yl}methyl)-N-{[3-(trifluoromethyl)phenyl]methyl}-1,3-oxazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V005-9981

Molecular Formula

C25H34F3N5O3 (C25 H34 F3 N5 O3)

Compound Name

2-({4-[2-hydroxy-3-(piperidin-1-yl)propyl]piperazin-1-yl}methyl)-N-{[3-(trifluoromethyl)phenyl]methyl}-1,3-oxazole-4-carboxamide

IUPAC name

2-({4-[2-hydroxy-3-(piperidin-1-yl)propyl]piperazin-1-yl}methyl)-N-{[3-(trifluoromethyl)phenyl]methyl}-13-oxazole-4-carboxamide

SMILES

OC(CN1CCCCC1)CN1CCN(Cc2nc(C(NCc3cccc(C(F)(F)F)c3)=O)co2)CC1

InChI

InChI=1S/C25H34F3N5O3/c26-25(27,28)20-6-4-5-19(13-20)14-29-24(35)22-18-36-23(30-22)17-33-11-9-32(10-12-33)16-21(34)15-31-7-2-1-3-8-31/h4-6,13,18,21,34H,1-3,7-12,14-17H2,(H,29,35)/t21-/m0/s1

InChI Key

CJHIRPPBWGBMIQ-NRFANRHFSA-N

MDL Number (MFCD)

MFCD19909230

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

509.57

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.871

Distribution Coefficient, logD

1.015

Water Solubility, LogSw

-2.39

Polar Surface Area

70.954

Acid Dissociation Constant (pKa)

12.49

Base Dissociation Constant (pKb)

8.19

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

60.00

V005-9981 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V005-9981 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V005-9981?
Check Price and Availability of V005-9981, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V005-9981 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V005-9981
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V005-9981
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V005-9981 available by request